Exercise for the Treatment of Cancer-Related Sarcopenia (NCT07498985) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Exercise for the Treatment of Cancer-Related Sarcopenia
Brazil78 participantsStarted 2026-04-01
Plain-language summary
Our primary objective is to assess the effects of exercise on cancer-related sarcopenia and its hallmarks, including muscle strength, muscle mass, and physical performance. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (QoL), cancer-related fatigue, and sleep quality. Additionally, we will explore the effects of exercise on bone and fat mass as secondary outcomes.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \> 18 years old women with a confirmed diagnosis of breast or gynecological cancer.
* Any level of sarcopenia (pre-sarcopenia, sarcopenia, or severe sarcopenia).
* Patients must have completed their primary treatment regimen (surgery, chemotherapy, and/or radiotherapy) for at least 2 weeks and up to 2 years before enrolment.
* have received the medical consent to be engaged in physical exercise programs.
Exclusion Criteria:
* The presence of one or more comorbidities that could potentially interfere with attendance or test results (e.g., other cancers or acute or chronic renal failure);
* Already in exercise programs comparable to the HERA program;
* Evidence of severe cardiovascular disease as a result of an electrocardiogram.